Arcoma AB (ARCOMA) - Total Liabilities

Latest as of September 2025: Skr24.58 Million SEK ≈ $2.64 Million USD

Based on the latest financial reports, Arcoma AB (ARCOMA) has total liabilities worth Skr24.58 Million SEK (≈ $2.64 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Arcoma AB - Total Liabilities Trend (2012–2024)

This chart illustrates how Arcoma AB's total liabilities have evolved over time, based on quarterly financial data. See ARCOMA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Arcoma AB Competitors by Total Liabilities

The table below lists competitors of Arcoma AB ranked by their total liabilities.

Company	Country	Total Liabilities
Kps AG XETRA:KSC	Germany	€73.86 Million
Ecoscience International Berhad KLSE:0255	Malaysia	RM105.04 Million
CMX GOLD+SILVER CORP. F:6GS	Germany	€733.54K
Miwon Chemical KO:134380	Korea	₩45.89 Billion
FIPP S.A. PA:FIPP	France	€28.40 Million
Fang Holdings Ltd NYSE:SFUNY	USA	$1.24 Billion
Greentech Metals Ltd AU:GRE	Australia	AU$403.63K
PROBIOTIX HEALTH LS-05 F:X90	Germany	€591.00K

Liability Composition Analysis (2012–2024)

This chart breaks down Arcoma AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Arcoma AB (ARCOMA) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.14	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.33	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Arcoma AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Arcoma AB (2012–2024)

The table below shows the annual total liabilities of Arcoma AB from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr21.13 Million ≈ $2.27 Million	-36.56%
2023-12-31	Skr33.30 Million ≈ $3.58 Million	-38.84%
2022-12-31	Skr54.46 Million ≈ $5.86 Million	+54.57%
2021-12-31	Skr35.23 Million ≈ $3.79 Million	-22.57%
2020-12-31	Skr45.50 Million ≈ $4.90 Million	+19.28%
2019-12-31	Skr38.14 Million ≈ $4.10 Million	+2.43%
2018-12-31	Skr37.24 Million ≈ $4.01 Million	+36.52%
2017-12-31	Skr27.28 Million ≈ $2.94 Million	-19.55%
2016-12-31	Skr33.90 Million ≈ $3.65 Million	-1.26%
2015-12-31	Skr34.34 Million ≈ $3.69 Million	-8.40%
2014-12-31	Skr37.48 Million ≈ $4.03 Million	-35.77%
2013-12-31	Skr58.35 Million ≈ $6.28 Million	+31.57%
2012-12-31	Skr44.35 Million ≈ $4.77 Million	--

About Arcoma AB

ST:ARCOMA Sweden Medical Devices

Market Cap

$13.61 Million

Skr126.49 Million SEK

Market Cap Rank

#26270 Global

#558 in Sweden

Share Price

Skr8.84

Change (1 day)

-6.55%

52-Week Range

Skr6.92 - Skr10.75

All Time High

Skr25.60